Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for CAR-T cell therapy
A new way to define T cells and what it means for cell therapy IP A new way to define T cells and what it means for cell therapy IP Reviewed by Dr Rose Hughes on Monday, January 19, 2026 Rating: 5
Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23) Pitfalls of cell therapy manufacturing IP - A case study (T 0868/23) Reviewed by Dr Rose Hughes on Monday, July 07, 2025 Rating: 5
Strict US written description requirement applied to CAR-T-cell therapy (Juno v Kite) Strict US written description requirement applied to CAR-T-cell therapy (Juno v Kite) Reviewed by Dr Rose Hughes on Sunday, January 09, 2022 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.